200 related articles for article (PubMed ID: 26077139)
1. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
Zhao H; Wu Y; Chen Y; Liu H
Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
[TBL] [Abstract][Full Text] [Related]
3. Association of JMJD2B and Hypoxia-Inducible Factor 1 Expressions with Poor Prognosis in Osteosarcoma.
Liu X; Zhang Q; Zhao Y; Xun J; Wu H; Feng H
Anal Cell Pathol (Amst); 2020; 2020():2563208. PubMed ID: 32802732
[TBL] [Abstract][Full Text] [Related]
4. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
[TBL] [Abstract][Full Text] [Related]
6. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
8. [Targeted inhibition of vascular endothelial growth factor (VEGF) expression in human osteosarcoma cell line by antisense VEGF165 cDNA promoted by hypoxia reaction element].
Wang Y; Wang R; Qiao H; Li JY; Peng TS; Li Y; Zhang M; Liang HZ; Qiu JS
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):588-91. PubMed ID: 16468311
[TBL] [Abstract][Full Text] [Related]
9. [Suppression of osteosarcoma in vitro by coexpression of antisense VEGF165 cDNA and thymidine kinase gene].
Wang Y; Qiao H; Peng TS; Li Y; Zhang M; Liang HZ; Qiu JS
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):190-5. PubMed ID: 17535687
[TBL] [Abstract][Full Text] [Related]
10. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
[TBL] [Abstract][Full Text] [Related]
11. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
14. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
15. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
[TBL] [Abstract][Full Text] [Related]
16. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
17. Outcome prediction of pulmonary metastasectomy can be evaluated using metastatic lesion in osteosarcoma patients.
Matsumoto I; Oda M; Yachi T; Tsuchiya H; Zen Y; Watanabe G
World J Surg; 2013 Aug; 37(8):1973-80. PubMed ID: 23564214
[TBL] [Abstract][Full Text] [Related]
18. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.
Rastogi S; Kumar R; Sankineani SR; Marimuthu K; Rijal L; Prakash S; Jalan D; Khan SA; Sharma MC
Int Orthop; 2012 Nov; 36(11):2315-21. PubMed ID: 23015149
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.
Zhao DQ; Chen J; Wu YF; Tian D; Zhou RX
Hepatogastroenterology; 2014 Jun; 61(132):1154-8. PubMed ID: 26158180
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
